Healthy Aging & Wellness Peptides
AOD-9604 — Metabolic & Fat-Loss Support
AOD-9604 is a modified fragment of human growth hormone — specifically the C-terminal portion (amino acids 176 to 191) responsible for GH's fat-metabolizing effects — without the IGF-1-raising or glucose-dysregulating effects of the full GH molecule. This makes AOD-9604 a highly targeted metabolic wellness tool with a favorable safety profile, particularly for those interested in fat-loss support as part of a structured wellness and nutrition program. At Vivere Drip Therapy in Carmel and Salinas, CA, AOD-9604 is used within individualized wellness plans guided by your provider.
How AOD-9604 Works
AOD-9604 works by stimulating lipolysis — the breakdown of stored triglycerides — in adipose tissue, while simultaneously inhibiting lipogenesis, the conversion of carbohydrates into fat. It activates beta-3 adrenergic receptors in fat cells, promoting the release of stored fat for energy use. Because it does not raise IGF-1, it avoids the insulin resistance and glucose dysregulation sometimes associated with full-dose growth hormone therapy. Clinical studies have shown particular efficacy in targeting visceral and abdominal fat — the metabolically harmful fat depot most resistant to conventional diet and exercise.
AOD-9604 as Part of a Structured Wellness Program
AOD-9604 is most effective as one component of a comprehensive metabolic wellness program — not as a standalone intervention. When combined with a structured nutrition approach, consistent physical activity, and appropriate sleep habits, it provides targeted metabolic support that complements the lifestyle foundation. Some providers combine AOD-9604 with growth hormone secretagogues like sermorelin for patients whose goals include both fat-loss support and body composition improvement. Your Vivere provider will design a program appropriate for your specific goals and health history.
Safety Profile
Because AOD-9604 does not raise IGF-1 levels and does not affect insulin or blood glucose, it avoids the theoretical concerns sometimes raised about high-dose GH therapy. It is generally well tolerated, with the most commonly reported effects being mild and local — injection site reactions that typically resolve quickly. As with any therapeutic peptide, AOD-9604 should be used under provider guidance with appropriate monitoring.
Frequently Asked Questions
Does AOD-9604 affect blood sugar?
No. Unlike full-dose growth hormone, AOD-9604 has no significant effect on insulin levels or blood glucose — a meaningful advantage for patients concerned about metabolic effects. This selectivity is one of the reasons it is favored over full GH supplementation for fat-loss support.
How long before AOD-9604 shows results?
Results vary by individual and depend heavily on accompanying lifestyle factors. Most patients who follow a structured nutrition and exercise program begin noticing changes in body composition after 8 to 12 weeks of consistent therapy. Abdominal fat is often the first area to respond.
These therapies are offered as part of individualized wellness programs and are not intended to diagnose, treat, cure, or prevent any disease. They are not a replacement for proper medical evaluation, imaging, rehabilitation, or other medically indicated care. Consult your provider to determine whether these wellness options are appropriate for your situation.
Related Topics
Book a Consultation
Every wellness plan at Vivere is individualized. Book a consultation at our Carmel or Salinas clinic to learn which options may be appropriate for you.